# Study of the Contraceptive Efficacy and Safety of a NOMAC-E2 Combined Oral Contraceptive (COC)(P06448)

> **NCT01656434** · PHASE3 · TERMINATED · sponsor: **Organon and Co** · enrollment: 3173 (actual)

## Conditions studied

- Contraception

## Interventions

- **DRUG:** NOMAC-E2
- **DRUG:** NETA-EE
- **OTHER:** Placebo
- **DRUG:** ethinylestradiol (EE)
- **DRUG:** ferrous fumarate

## Key facts

- **NCT ID:** NCT01656434
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-11-02
- **Primary completion:** 2014-02-12
- **Final completion:** 2014-02-12
- **Target enrollment:** 3173 (ACTUAL)
- **Why stopped:** Business reasons
- **Last updated:** 2024-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01656434

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01656434, "Study of the Contraceptive Efficacy and Safety of a NOMAC-E2 Combined Oral Contraceptive (COC)(P06448)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01656434. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*